Sampling plan for assessing the quality of medicines and medical devices in circulation in the Republic of Kazakhstan for 2023.
Manufacturers (registration certificate holders of medicines, authorized representatives of the manufacturer of medical devices), based on the Rules for selection from the market, including medical organizations, medicines and medical devices subject to quality control taking into account the risk-based approach, registered in the Republic of Kazakhstan, approved by order of the Minister of Health of the Republic of Kazakhstan dated December 24, 2020, No. ҚР ДСМ-323/2020, we place a sampling plan for assessing the quality of medicines and medical devices in circulation in the territory of the Republic of Kazakhstan for 2023.
New Labeling Requirements
The NDDA has announced new rules for labeling medicines and medical devices. The new rules prescribe the scope of information to be included in the labeling and how it should be provided.
How can RegDesk help?
RegDesk is a holistic Regulatory Information Management System that provides medical device and pharma companies with regulatory intelligence for over 120 markets worldwide. It can help you prepare and publish global applications, manage standards, run change assessments, and obtain real-time alerts on regulatory changes through a centralized platform. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Global expansion has never been this simple.